American Laboratory Products Company (ALPCO) products

Our reliable testing solutions allow for the treatment, control and prevention of conditions associated with allergies and infectious disease. The immune system protects our body against several factors including allergens, harmful pathogens and foreign particles. Allergies involve an exaggerated response of the immune system and are among the most common chronic conditions worldwide. Infectious disease agents are also one of the leading contributors to debilitating and sometimes fatal conditions. Therefore, scientists look to understand interactions between microbes and the immune system.

We offer a range of research tools required to identify novel Cardiovascular Disease and Oxidative Health biomarkers, enabling scientists to test their relevance in basic, preclinical and clinical studies. Cardiovascular Disease (CVD) encompasses a constellation of diseases related to the heart and/or circulatory system. Two primary risk factors for CVD include obesity and Type 2 Diabetes, both of which have continued to be on the rise over the past few decades. It is evident that regardless of the advancements in scientific knowledge of the disease and the improvements in diagnosis and treatment, more research is necessary to further our understanding of CVD.

Our extensive selection of antibodies is validated for use in flow cytometry, immunohistochemistry and other applications, and allows researchers to identify hundreds of intracellular and extracellular proteins. Antibodies are produced by the immune system in response to antigens. Though the general structure of antibodies is very similar, a small variation in the antigen-binding site of the protein allows for the specific recognition of a single antigen.

We strive to help scientists better understand the relationship between key regulators of bone metabolism. Bone metabolism is a continual, cyclic interplay of bone growth and resorption. The dynamic relationship between osteoclasts, osteoblasts and an array of hormonal and regulatory influences carefully orchestrates this process. The relative levels of these signaling molecules dictate whether healthy, balanced bone metabolism ensues. Disturbances to this delicate equilibrium, where reabsorption is greater than growth, can weaken the skeletal architecture and put one at risk for the development of chronic and debilitating diseases, such as osteoporosis.

As a leading provider of testing solutions for the Diabetes and Obesity research community, we support scientists’ efforts to gain a greater understanding of these conditions. With no cure for Type 1 or Type 2 Diabetes and a lack of effective obesity treatments, scientists in the Diabetes and Obesity fields are continually in need of new methods to advance their studies. As these needs progress, we strive to provide Diabetes and Obesity investigators with the necessary tools to identify key biomarkers to achieve their research goals.